Risk factors for non-cardiac chest pain in the community

Alimentary Pharmacology and Therapeutics

Volumn 22, Issue 10, 2005, Pages 1023-1031

  Wise, J L ^a   Locke, G R ^a   Zinsmeister, A R ^a   Talley, N J ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRHEUMATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FAMILY HISTORY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON CARDIAC CHEST PAIN; OBESITY; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT DISEASE; REFLUX ESOPHAGITIS; RISK ASSESSMENT; RISK FACTOR; THORAX PAIN; UNITED STATES;

ADULT; AGED; CHEST PAIN; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH BEHAVIOR; HUMANS; LOGISTIC MODELS; MAINE; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS;

EID: 27744575889     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02666.x     Document Type: Article

References (26)

1. Fang J, Bjorkman D. A critical approach to noncardiac chest pain: pathophysiology, diagnosis, and treatment. Am J Gastroenterol 2001; 96: 958-68.
2. Eslick GD, Coulshed DS, Talley NJ. Review article: The burden of illness of non-cardiac chest pain. Aliment Pharmacol Ther 2002; 16: 1217-23.
3. Eslick GD. Usefulness of chest pain character and location as diagnostic indicators of an acute coronary syndrome. Am J Cardiol 2005; 95: 1228-31.
4. Chambers J, Bass C. Atypical chest pain: looking beyond the heart. QJM 1998; 91: 239-44.
5. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56.
6. Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting - a population-based study. Aliment Pharmacol Ther 2003; 17: 1115-24.
7. Lacima G, Grande L, Pera M, Francino A, Ros E. Utility of ambulatory 24-hour esophageal pH and motility monitoring in noncardiac chest pain: report of 90 patients and review of the literature. Dig Dis Sci 2003; 48: 952-61.
8. Stahl WG, Beton RR, Johnson CS, Brown CL, Waring JP. Diagnosis and treatment of patients with gastroesophageal reflux and noncardiac chest pain. South Med J 1994; 87: 739-42.
9. Fass R, Fennerty MB, Johnson C, Camargo L, Sampliner RE. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease. J Clin Gastroenterol 1999; 28: 36-9.
10. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain [see comment]. Gastroenterology 1998; 115: 42-9.
11. Richter JE, Hewson EG, Sinclair JW, Dalton CB. Acid perfusion test and 24-hour esophageal pH monitoring with symptom index. Comparison of tests for esophageal acid sensitivity. Dig Dis Sci 1991; 36: 565-71.
12. Melton LJ III. History of the Rochester epidemiology project. Mayo Clin Proc 1996; 71: 266-74.
13. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-47.
14. Attanasio VAF, Blanchard EB, Arena JG. Psychometric properties of the SUNYA revision of the psychosomatic symptom checklist. J Behav Med 1984; 7: 247-58.
15. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999; 106: 642-9.
16. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003; 290: 66-72.
17. Wajed SA, Streets CG, Bremner CG, DeMeester TR. Elevated body mass disrupts the barrier to gastroesophageal reflux. Arch Surg 2001; 136: 1014-8; discussion 1018-9
18. Lundell L, Ruth M, Sandberg N, Bove-Nielsen M. Does massive obesity promote abnormal gastroesophageal reflux? Dig Dis Sci 1995; 40: 1632-5.
19. Fisher BL, Pennathur A, Mutnick JL, Little AG. Obesity correlates with gastroesophageal reflux. Dig Dis Sci 1999; 44: 2290-4.
20. Melissas J, Christodoulakis M, Spyridakis M, et al. Disorders associated with clinically severe obesity: significant improvement after surgical weight reduction. South Med J 1998; 91: 1143-8.
21. Groessl EJ, Kaplan RM, Barrett-Connor E, Ganiats TG. Body mass index and quality of well-being in a community of older adults. Am J Prev Med 2004; 26: 126-9.
22. Marcus DA. Obesity and the impact of chronic pain. Clin J Pain 2004; 20: 186-91.
23. Mason JC. NSAIDs and the oesophagus. Eur J Gastroenterol Hepatol 1999; 11: 369-73.
24. Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR III, Pedersen NL. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 2002; 122: 55-9.
25. Romero Y, Locke GR III. Is there a GERD gene [comment]? Am J Gastroenterol 1999; 94: 1127-9.
26. Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 2004; 126: 660-4.